Search - tctmd.com

Displaying 861 - 880 of 1172

Sort: Relevancy | Date

News Daily News

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

L.A. McKeown

November 17, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

Presentation

Effect of PCI on Long-term Survivalin Patients With Stable Ischemic Heart Disease

Presenter: Steven P. Sedlis

November 10, 2015

News Daily News

COURAGE at 15 Years: Still No Survival Advantage for PCI

L.A. McKeown

November 10, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Industry News

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

November 02, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

Presentation TCT 2015

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Presenter: John P. Cheatham, Carlos Pedra, Ulrich Schaefer

October 13, 2015

Presentation TCT 2015

Ischemic Heart Disease and Acute Coronary Syndrome

Presenter: Hugh J. Linnehan, Bernard J. Gersh

October 13, 2015

Presentation TCT 2015

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

Presenter: Bernard J. Gersh, Stephen D. Wiviott, Giora Weisz

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

Presentation TCT 2015

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Presenter: Morton J. Kern, Jan J. Piek, Tim P. van de Hoef

October 12, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

News Daily News

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Todd Neale

September 21, 2015

News Industry News

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

September 17, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Industry News

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

August 26, 2015

Advertisement

Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

Effect of PCI on Long-term Survivalin Patients With Stable Ischemic Heart Disease

COURAGE at 15 Years: Still No Survival Advantage for PCI

Post-TAVR Myocardial Injury Linked to Mortality

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

My Takeaways From TCT 2015

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Ischemic Heart Disease and Acute Coronary Syndrome

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content